Atmos Energy Corporation vs Canopy Growth Corp — how do they compare? Atmos Energy Corporation trades at $168.76 (market cap $28.59B), while Canopy Growth Corp trades at $1 (market cap $421.10M). The key difference: Atmos Energy Corporation is far larger — about 67.9× Canopy Growth Corp's market cap, and Atmos Energy Corporation pays a 2.36% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| ATO | CGC | |
|---|---|---|
Market Cap | $28.59B | $421.10M |
Sector | Utilities | Health |
52-Week High | $192.25 | $1.92 |
52-Week Low | $162.44 | $0.86 |
Enterprise Value | $38.40B | $378.55M |
Dividend Yield | 2.36% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CGC trades at $0.95, down 1.86% in the last session, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year, beating estimates, but continues to post net losses. Recent news highlights expansion in European cannabis markets and cost-cutting efforts, while the stock remains volatile amid regulatory uncertainty.
Outlook is cautious due to persistent losses and high debt, though improving cash flow and revenue growth offer potential upside. Key risks include regulatory delays in U.S. cannabis rescheduling and competitive pressures. Investors should weigh the speculative nature against any positive regulatory catalysts.
Trailing returns across standard periods
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →